Catalyst Wire Dossier Catalyst Wire Dossier

VMD-3866 Gel

VMD-3866 · VM Therapeutics LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VMD-3866 Gel, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN) [Phase 2]

See pricing